Michael Bologna
Directeur/Membre du Conseil chez Arvelle Therapeutics International GmbH
Profil
Mike Bologna, Partner at NovaQuest Capital Management, has over 20 years of experience in the biomedical industry across pharmaceuticals and health care investing.
He is responsible for sourcing, negotiating, due diligence, structuring of investment opportunities, and post-close investment management.
In addition to his work on specific investment aspects, Mr. Bologna heads the Due Diligence and Alliance Management functions for the firm.
He joined the NovaQuest business unit at IQVIA (formerly Quintiles) in 2007 and served as a transaction and due diligence leader.
Mr. Bologna had material involvement in the structuring, negotiation, and management of a wide variety of product-based and company investments, prior to the formation of NovaQuest Capital Management in 2010.
Prior to joining NovaQuest, Mr. Bologna served in a variety of roles with EMD Pharmaceuticals (U.S.
subsidiary of Merck KGaA) and Eli Lilly and Company.
He worked in corporate development, market research, and commercial new product planning.
Mr. Bologna earned a BS in Nursing from University of Michigan and MBA from Fuqua School of Business at Duke University.
Postes actifs de Michael Bologna
Sociétés | Poste | Début |
---|---|---|
NovaQuest Capital Management LLC
NovaQuest Capital Management LLC Investment ManagersFinance NovaQuest Capital Management LLC (NovaQuest Capital Management) is a private equity firm founded in 2010 by John Layton Bradley and Jonathan Edward Tunnicliffe. The firm is headquartered in Raleigh, North Carolina. | Private Equity Investor | 08/07/2011 |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Bologna
Sociétés | Poste | Fin |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Corporate Officer/Principal | - |
Formation de Michael Bologna
University of Michigan | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Entreprise privées | 4 |
---|---|
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Health Technology |
NovaQuest Capital Management LLC
NovaQuest Capital Management LLC Investment ManagersFinance NovaQuest Capital Management LLC (NovaQuest Capital Management) is a private equity firm founded in 2010 by John Layton Bradley and Jonathan Edward Tunnicliffe. The firm is headquartered in Raleigh, North Carolina. | Finance |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Health Technology |